Non-interventional Study of Avelumab in the Treatment of Urothelial Cancer - The AVENUE NIS - AB 82/21 of AUO First-line Maintenance Therapy in Adult Patients with locally advanced or metastatic Urothelial Cancer who are progression-free after platinum-based Chemotherapy

被引：0
|
作者：
不详
机构：
来源：
UROLOGIE | 2023年 / 62卷 / 06期
关键词：
D O I：
10.1007/s00120-023-02120-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：672 / 673
页数：2
相关论文
共 50 条
  • [1] First-line Maintenance Therapy in adult Patients with locally advanced or metastatic Urothelial Carcinoma who are progression-free after platinum-based Chemotherapy
    Rexer, Heidrun
    Gschwend, Jurgen
    Merseburger, Axel S.
    AKTUELLE UROLOGIE, 2024, 55 (04) : 297 - 298
  • [2] Real world progression-free survival in patients with advanced or metastatic urothelial cancer treated with first-line platinum-based chemotherapy
    Nikolaidis, Christos
    Li, Chen
    Lee, Chooi
    Mecke, Almut
    Reyes-Rivera, Irmarie
    Schroder, Carsten
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 319 - 319
  • [3] Real world outcomes for maintenance avelumab treatment in locally advanced/metastatic urothelial cancer after platinum-based chemotherapy.
    Rehan, Ahmed
    Qureshi, Muneeb
    Aydin, Sabin Goktas
    O'Connor, Kate
    Serra, Maria
    Charnley, Natalie
    Spurgeon, Laura
    Muazzam, Iqtedar
    Bansal, Vikram
    Vasudev, Naveen
    Coe, Faye
    Kagzi, Mohammed Mubashir
    Din, Omar
    Leach, Diane
    Hubbard, Rachel
    Catto, James W. F.
    Hussain, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [4] Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy
    Sharma, Padmanee
    Sohn, Joohyuk
    Shin, Sang Joon
    Oh, Do-Youn
    Keam, Bhumsuk
    Lee, Hyo Jin
    Gizzi, Marco
    Kalinka, Ewa
    de Vos, Filip Y. F. L.
    Ruscica, Dario
    Ferro, Salvatore
    Xiao, Feng
    Baverel, Paul
    Chen, Cecil Chi-Keung
    Asubonteng, Kobby
    Morsli, Nassim
    Dirix, Luc
    CLINICAL CANCER RESEARCH, 2020, 26 (01) : 61 - 70
  • [5] First-line treatment for locally advanced or metastatic urothelial carcinoma: a randomized controlled phase III study comparing pembrolizumab with and without platinum-based combination chemotherapy and chemotherapy alone in patients with advanced or metastatic urothelial carcinoma (Keynote-361) AB 54/16 of AUO
    Rexer, H.
    Ohlmann, C. -H.
    Retz, M.
    AKTUELLE UROLOGIE, 2018, 49 (01) : 21 - 22
  • [6] Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab
    Sato, Ryo
    Inamoto, Teruo
    Matsushita, Yuto
    Takemura, Ayana
    Uchimoto, Taizo
    Sano, Asuka
    Tanaka, Hiroki
    Ishikawa, Gaku
    Watanabe, Kyohei
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Sugiyama, Takayuki
    Otsuka, Atsushi
    Harada, Ken-ichi
    Azuma, Haruhito
    Miyake, Hideaki
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (09) : 730 - 736
  • [7] First-line Therapy for locally advanced or metastatic Urothelial Carcinoma A randomized, controlled Phase-III-Trial comparing Pembrolizumab with or without platinum-based Combination Chemotherapy and Chemotherapy only in Patients with advanced or metastatic Urothelial Carcinoma (Keynote-361-AB 54/16 of the AUO)
    Rexer, H.
    Ohlmann, C. -H.
    Retz, M.
    UROLOGE, 2017, 56 (05): : 659 - 661
  • [8] MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001)
    Gupta, Shilpa
    Ballman, Karla V.
    Galsky, Matt D.
    Morris, Michael J.
    Chen, Ronald C.
    Chan, Timothy A.
    Dercle, Laurent
    Wen, Yujia
    Sridhar, Srikala S.
    Yen, Aihua Edward
    Grivas, Petros
    Tan, Alan
    Baghaie, Shiva
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).
    Gupta, Shilpa
    Ballman, Karla V.
    Galsky, Matt D.
    Morris, Michael J.
    Sridhar, Srikala S.
    Chen, Ronald C.
    Chan, Timothy An-Thy
    Wen, Yujia
    Grivas, Petros
    Tan, Alan
    Baghaie, Shiva
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Trial in progress: A phase 2, randomized, open-label study of trilaciclib with first-line, platinum-based chemotherapy and avelumab maintenance in untreated patients with locally advanced or metastatic urothelial carcinoma (PRESERVE 3).
    Sonpavde, Guru P.
    Grivas, Petros
    Milowsky, Matthew I.
    Galsky, Matt D.
    Malik, Rajesh K.
    Beelen, Andrew Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345